Article
ACR Convergence is truly drinking from the proverbial fire hose. It’s a beautiful mash-up of basic science and treatment updates meets guidelines, recommendations, and disease identification.
All News
Article
In a post hoc analysis of the phase 2 NOBILITY trial, researchers found that treatment with obinutuzumab—an antibody that targets a protein expressed on certain immune cells—was superior to placebo for preserving kidney function and preventing flares in patients with lupus nephritis, a kidney con
Article
Dr. Jack Cush reviews RheumNow's top entries the PMR Campaign, news, journal reports and regulatory actions.
Article
Among patients with systemic lupus erythematosus (SLE), high titers of anti-phospholipid (aPL) antibodies were most prevalent in whites and Latinos and less so for Black and Asian individuals, researchers found.
Article
Dr. Jack Cush discusses the news, journal articles and regulatory actions. This week we discuss JAKne, DLE and SLE and more.
Article
EULAR has published updated recommendations for the management of systemic lupus erythematosus (SLE) based on new evidence and expert opinion - formulationg five overarching principles and 13 recommendations.
Article
This week on the podcast, Dr. Jack Cush is joined by special guest, Dr. Kathryn Dao to review the news and journal reports from the past week on RheumNow.com. They discuss unmet needs in gout, obesity and CV disease in PsA and should you check ANCA antibodies in SLE?
Article
Daily hydroxychloroquine (HCQ) is better than an apple a day; as a new study shows that adherence to the antimalarial agent significantly lowers future risk of cardiovascular events in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients.
Article
This week, Dr. Jack Cush reviews the news with special guest, Dr. Janet Pope. They discuss "Not-non-Inferior", large scale genetic screening, Zoster risk w/ newer lupus drugs, tapering, RA referral problems and the TNR webinar session on "ORAL Surveillance Revisited".
Article
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow, and introduces our September campaign - "Hard Decisions in RA".
Bella Mehta
Tweet
Managing stress is a key in many autoimmune diseases. Do not forget non pharmacological techniques.
@RheumNow #ACR23 https://t.co/pACxOSaN7A
David Liew
Tweet
Pregnancy is complicated for women with rheumatic diseases.
There's a pathway to healthy mothers & babies, but it takes:
- planning
- the right meds
- the right disease control.
@drbags71 #ACR23 Review Course @RheumNow https://t.co/epdDIVGPye
David Liew
Tweet
@drbags71 @RheumNow Too often we don't leave women of childbearing age with a plan, if they do get pregnant. And we need to help them get ready, for whatever they want, so we can avoid bad outcomes - and all the consequences of that.
@drbags71 #ACR23 Review COurse @RheumNow https://t.co/HLg6KjCiJX
David Liew
Tweet
@drbags71 @RheumNow So approach @drbags71:
HOP-STEP
- proactively ask/communicate
- make difficult discussions easier with these truly amazing guides:
https://t.co/9AJIrF9bsQ counselling
https://t.co/618mrifi3f dr/pt Rx plans
⬆️**bookmark these**
- share
do not miss!
#ACR23 Review Course @RheumNow https://t.co/vWwJLu2HWG
Dr. John Cush
Tweet
BMJ State of the Art (full read) review of ADVANCES in LUPUS THERAPY (Morand EF, et al).
- Recent SLE RCTs
- Pathogenesis, genetics, epigenetics
- Phenotypes
- Emerging treatments
- Guidelines on Rx
https://t.co/qZFvQkaFeO https://t.co/r9IriOR8FF
Dr. John Cush
Tweet
RheumNow Live registration is NOW OPEN! Early bird pricing through 11/30/2023. Register today!
https://t.co/1SjBiM7Daj https://t.co/w2cFcj85r5
Dr. John Cush
Tweet
Anti-Phospholipid Antibodies - Infrequent in Certain Groups
Among patients with SLE, high titers of anti-phospholipid (aPL) antibodies were most prevalent in whites and Latinos and less so for Black and Asian individuals, researchers found.
https://t.co/qQygcS3Ktw https://t.co/FVKlvFuuFn
Dr. John Cush
Tweet
2023 EULAR Lupus Management Recommendations
EULAR has published updated recommendations for the management of systemic lupus erythematosus (SLE) based on new evidence and expert opinion - formulationg five overarching principles and 13 recommendations.
https://t.co/9PKvsEUTM3 https://t.co/gElp6tyEQZ
Dr. John Cush
Tweet
2023 EULAR Lupus Management Recommendations
EULAR has published updated recommendations for the management of systemic lupus erythematosus (SLE) based on new evidence and expert opinion - formulationg five overarching principles and 13 recommendations.
https://t.co/Fzh8F33u3U https://t.co/2baAVsm8Bo
Dr. John Cush
Tweet
1 in 3 of our pts are on steroids; nice ARD full read review of important papers on steroids 2022-23 written by Prof J Bijlsma, covering:
Mechanisms of action
CV AE
Bone Effects
Infections, COVID-19
Clin trials
Benefit vs Harm
Tapering
GC Guidelines
https://t.co/LnqLk8eKgn https://t.co/5xfvic5YIX
